A New Chapter in International Partnership
The International Society of Atopic Dermatitis (ISAD) is pleased to announce the establishment of a The International Society of Atopic Dermatitis (ISAD) and the European Academy of Allergy and Clinical Immunology (EAACI) are proud to announce a formal strategic partnership, cemented by a Memorandum of Understanding signed in February 2026.
This collaboration unites two global leaders to bridge the fields of dermatology, allergy, and clinical immunology. By aligning our expertise, we aim to accelerate progress in atopic dermatitis research and transform patient-centered care through a truly integrated approach.
Key Benefits for Our Members:
- Scientific Synergy:
Joint sessions at premier global congresses, featuring cross-disciplinary insights. - Dual Engagement:
A new membership framework providing ISAD members streamlined access to EAACI’s working groups, educational platforms, and resources. - Global Impact:
Unified efforts in clinical guideline development, specialized training, and global health advocacy.
Looking Ahead: SAM 2027
The first major milestone of this alliance will be the EAACI Skin Allergy Meeting (SAM) in Paris, 11–13 March 2027. ISAD will play an active role in the scientific program, hosting dedicated joint sessions that explore the intersection of skin biology and immune mechanisms.
Together, we are building a more connected international community to tackle the complexities of atopic dermatitis and allergic diseases.